Insights: News Releases Kilpatrick Townsend’s Alyson Wooten Featured Speaker at Abbreviated New Drug Application and Paragraph IV Certification: Critical Insights in 2015 Live Webcast

ATLANTA (August 19) -- Kilpatrick Townsend & Stockton announced today that attorney Alyson Wooten will serve as a featured speaker at a live webcast presented by The Knowledge Group. The webcast, which will be held Tuesday, August 25, is titled, “Abbreviated New Drug Application (ANDA) and Paragraph IV Certification: Critical Insights in 2015.”

Dr. Wooten will discuss, “The Use of Inter Partes Review Petitions in Generic Drug Litigation.” Her session will focus on the review of the competing statutes: Hatch-Waxman vs. AIA, strategies for use of IPR in the pharmaceutical context, and special issues with concurrent ANDA litigation.

For more information on the webcast, please click here.

Dr. Wooten, PharmD, focuses her practice on patent litigation across technologies including telecommunication systems, software systems, pharmaceutical and chemical products, medical devices and financial related technologies. She also has significant experience in strategic IP counseling and licensing. Registered as a patent attorney and pharmacist, Dr. Wooten has broad experience in the pharmaceutical industry, including medical services, regulatory, marketing and clinical trial analysis.

For more information about Kilpatrick Townsend, please visit:

Follow the firm on Twitter: @KTS_Law.


Latest Thinking

View more Insights
Insights Center
If you would like to receive related insights and information from Kilpatrick Townsend, please provide your contact details by filling out the form and clicking “Agree.” If you would like to access the PDF only, please click “Download Only.”